Topics

Glioblastoma | Outcomes

Home > Publications > Topics > Glioblastoma > Outcomes

□ OVERVIEW

OVERALL MANAGEMENT

□ AGE

□ BIOPSY-ONLY

□ BUTTERFLY GLIOBLASTOMA

□ COGNITION

□ COMORBIDITIES

□ ELDERLY PATIENTS

□ END OF LIFE

□ GENDER

□ IDH-wWithoutContrEnh

□ IMAGING TIMING

□ INTEGRATIVE MEDICINE

□ IMAGING

□ INTRAOPERATIVE RADIOTHER

□ PLATELET-TO-LYMPHOCYTE RATIO (PLR) AND NEUTROPHIL-TO-LYMPHOCYTE RATIO (NLR)

□ PREOPERATIVE BLOOD ELEMENTS

□ RED BLOOD CELL TRANSFUSION

□ RECURRENCE

□ REHABILITATION

□ SPINAL CORD

□ STUPP PROTOCOL

□ SURVIVAL

□ TRANSPLANTATION

CHEMOTHERAPY

□ CHEMOTHERAPY TIMING

□ NEOADJUVANT CHEMOTHER

□ TEMOZOLOMIDE

ELDERLY PATIENTS

□ PERFORMANCE STATUS

ELECTRIC / MAGNETIC FIELDS

□ TUMOR TREATING FIELDS

IMMUNOTHERAPY

□ DENDRITIC CELLS

OFF-LABEL MEDICATIONS

□ ANTIBIOTICS

□ ANTIDEPRESSANT DRUGS

□ ANTIEPILEPTIC DRUGS

□ DOPAMINE AGONISTS

RADIOTHERAPY

□ ADAPTIVE RADIAT THER

□ MARGINS

□ RADIOTHERAPY FRACTIONAT

□ RADIOSURGERY

□ RADIOTHERAPY TIMING

□ RE-IRRADIATION

SUPPORTIVE CARE

□ PALLIATIVE CARE

SURGERY

□ EPILEPSY

□ RE-RESECTION

□ RESECTION EXTENT

ULTRASOUNDS

□ LASER INTERST THERMAL THER